(Q39220098)

10 September 2017

title

Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide (English)

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

29 March 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

29 March 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

29 March 2022

2

Kastin AJ

1 reference

10 September 2017

R. M. Kostrzewa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A30981

29 March 2022

S. K. Sobrian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A30981

29 March 2022

language of work or name

English

0 references

1 September 1978

1 reference

full work available at URL

10 September 2017

https://api.elsevier.com/content/article/PII:009130577890299X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

https://api.elsevier.com/content/article/PII:009130577890299X?httpAccept=text/plain

29 March 2022

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Pharmacology, Biochemistry and Behavior

29 March 2022

published in

1 reference

10 September 2017

volume

9

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

375-378

1 reference

Potentiation of levodopa effect by intravenous L-prolyl-L-leucyl-glycine amide in man

10 September 2017

cites work

1

2

683

Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man (English)

author name string

Barbeau

1975

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Neurologically active peptides

29 March 2022

3

5

159

Neurologically active peptides (English)

author name string

Barbeau

1976

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain

29 March 2022

5

5

117

Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain (English)

author name string

Christensen

1976

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors

29 March 2022

0 references

Tyrosine hydroxylase in rat brain--cofactor requirements, regional and subcellular distribution

7

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

28 October 2022

Q64870155

8

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Dopamine synthesis: stimulation by a hypothalamic factor

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Intensification of central catecholaminergic and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

DOPA decarboxylase in the developing rat brain

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF).

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

DOPA Potentiation in Ablated Animals and Brain Levels of Biogenic Amines in Intact Animals after Prolyl-leucylglycinamide

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Reserpine selectively increases tyrosine hydroxylase and dopamine-beta-hydroxylase enzyme protein in central noradrenergic neurons

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Possible association of increased rat behavioral effects and increased striatal dopamine and norepinephrine levels during the DOPA-potentiation test

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Prolyl-leucyl-glycinamide (PLG); regional effects on alpha-MPT-induced catecholamine disappearance in rat brain

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0091-3057(78)90299-X

28 October 2022

Identifiers

1 reference

10 September 2017

1 reference